Concepedia
Statistics
Publications
6
Citations
624
H-Index
Active since
2017
Affiliations
Dana-Farber Cancer Institute(Current)
Memorial Sloan Kettering Cancer Center
University of Iowa
Moffitt Cancer Center
University of California, San Francisco
Josh Mailman is an author at Dana-Farber Cancer Institute specializing in oncology, medicine, and nuclear medicine.
Publications per year
2017–2025
Appropriate Use Criteria for Somatostatin Receptor PET Imaging in Neuroendocrine Tumors
Thomas A. Hope, Emily K. Bergsland, Murat Fani Bozkurt et al. · Journal of Nuclear Medicine · 2017 · 351 citations · Full text
Medicine, Nuclear Medicine, Oncology +17
NANETS/SNMMI Consensus Statement on Patient Selection and Appropriate Use of <sup>177</sup>Lu-DOTATATE Peptide Receptor Radionuclide Therapy
Thomas A. Hope, Lisa Bodei, Jennifer A. Chan et al. · Journal of Nuclear Medicine · 2020 · 122 citations · Full text
Systemic Therapy for Tumor Control in Metastatic Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors: ASCO Guideline
Jaydira Del Rivero, Kimberly Perez, Erin B. Kennedy et al. · Journal of Clinical Oncology · 2023 · 93 citations
Medicine, Oncology, Surgery +17
A Framework for Patient-Centered Pathways of Care for Radiopharmaceutical Therapy: An ASTRO Consensus Document
John M. Buatti, Daniel A. Pryma, Ana P. Kiess et al. · International Journal of Radiation Oncology*Biology*Physics · 2020 · 23 citations · Full text
Medicine, Nuclear Medicine, Radiology +16
Patient Advocates and Researchers as Partners in Cancer Research: A Winning Combination
Laura Porter, Karyn A. Goodman, Josh Mailman et al. · American Society of Clinical Oncology Educational Book · 2023 · 23 citations · Full text
Nursing, Oncology, Advocacy +16
1–5 of 6